GigaGen Initiates Large-Scale Manufacturing of its First-in-Class RecombinantHyperimmune Drug for COVID-19, GIGA-2050 September 9, 2020 News / GigaGen Initiates Large-Scale Manufacturing of its First-in-Class RecombinantHyperimmune Drug for COVID-19, GIGA-2050 gigagen_manufacturing_clean_-_9sept20Download